Page 2 - Tial Bush News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume Increase

Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume Increase
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tial bushAntoine yverTanager wealth managementMorgan stanleyCentessa pharmaceuticalsCentessa pharmaceuticals trading downSio capital managementHedge funds weigh in on centessa pharmaceuticalsNews ratings for centessa pharmaceuticals dailySecurities exchange commissionGet free reportPharmaceuticals trading downExchange commissionWealth managementCapital managementCentessa pharmaceuticals daily

Centessa Pharmaceuticals (NASDAQ:CNTA) Trading 11 7% Higher

Centessa Pharmaceuticals (NASDAQ:CNTA) Trading 11 7% Higher
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Antoine yverTial bushCentessa pharmaceuticals company profileInstitutional trading of centessa pharmaceuticalsGeode capital managementGoldman sachs group incTanager wealth managementSecurities exchange commissionNews ratings for centessa pharmaceuticals dailyPrelude capital managementCentessa pharmaceuticalsCentessa pharmaceuticals stockGet free reportExchange commissionWealth managementCapital management

Centessa Pharmaceuticals (NASDAQ:CNTA) Price Target Increased to $15 00 by Analysts at BMO Capital Markets

Centessa Pharmaceuticals (NASDAQ:CNTA) Price Target Increased to $15 00 by Analysts at BMO Capital Markets
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tial bushAntoine yverCentessa pharmaceuticals stock performanceCentessa pharmaceuticalsGeode capital managementPrelude capital managementInsider activity at centessa pharmaceuticalsAnalyst recommendations for centessa pharmaceuticalsJpmorgan chase coCentessa pharmaceuticals company profileBarclays plcNews ratings for centessa pharmaceuticals dailyFree reportModerate buyGet free reportState equity partners

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 5 5%

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) were down 5.5% on Monday . The stock traded as low as $6.81 and last traded at $6.90. Approximately 62,297 shares changed hands during trading, a decline of 62% from the average daily volume of 162,998 shares. The stock had previously closed at $7.30. Analyst […]

Tial bushAntoine yverBarclays plcNews ratings for centessa pharmaceuticals dailyGoldman sachs group incCentessa pharmaceuticalsSusquehanna international groupCentessa pharmaceuticals price performanceInsider transactions at centessa pharmaceuticalsRenaissance technologiesJpmorgan chase coCentessa pharmaceuticals company profileInstitutional trading of centessa pharmaceuticalsGet free reportInternational groupGoldman sachs group

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 5 3%

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) shares fell 5.3% during mid-day trading on Tuesday . The company traded as low as $7.50 and last traded at $7.51. 45,999 shares changed hands during mid-day trading, a decline of 72% from the average session volume of 164,245 shares. The stock had previously closed at $7.93. […]

Antoine yverTial bushPrelude capital managementGeode capital managementCentessa pharmaceuticals price performanceSecurities exchange commissionCentessa pharmaceuticalsHedge funds weigh in on centessa pharmaceuticalsBarclays plcNews ratings for centessa pharmaceuticals dailyJpmorgan chase coGet free reportExchange commissionState equity partnersCapital managementCentessa pharmaceuticals daily